GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (LTS:0QCO) » Definitions » Other Current Payables

Pharming Group (LTS:0QCO) Other Current Payables : €0.0 Mil (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Pharming Group Other Current Payables?

Pharming Group's Other Current Payables for the quarter that ended in Mar. 2025 was €0.0 Mil.

Pharming Group's quarterly Other Current Payables increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then declined from Dec. 2024 (€0.0 Mil) to Mar. 2025 (€0.0 Mil).

Pharming Group's annual Other Current Payables stayed the same from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil) but then increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil).

Pharming Group Other Current Payables Historical Data

The historical data trend for Pharming Group's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Other Current Payables Chart

Pharming Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.03 - - -

Pharming Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharming Group Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Pharming Group Other Current Payables Related Terms

Thank you for viewing the detailed overview of Pharming Group's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (LTS:0QCO) » Definitions » Other Current Payables
Comparable Companies
XAMS:VVY XAMS:GLPG VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN HKSE:02269 SHSE:603392
Traded in Other Exchanges
PHAR:USA PHGUF:USA PHARM:Netherlands PHGN:Germany
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Website
https://www.pharming.com
Pharming Group is a biopharmaceutical company. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome. In addition, the firm's development pipeline includes KL1333, a potential first-in-disease asset for mitochondrial DNA-driven primary mitochondrial diseases. The company's reportable segments are RUCONEST, which derives maximum revenue, Joenja, U.S., and Europe and the Rest of the World (RoW). Geographically, it derives maximum revenue from the United States.

Pharming Group Headlines

No Headlines